khn pharmacy rachel nicole schlechty

Upload: james-lindon

Post on 02-Jun-2018

219 views

Category:

Documents


0 download

TRANSCRIPT

  • 8/10/2019 Khn Pharmacy Rachel Nicole Schlechty

    1/3

    NOTICE OF OPPORTUNITY FOR HEARING

    November 19, 2014

    S

    -

    D

    - M U S T H A V k

    11r

    I . t

    . 4 O K

    urrPJ

    T 4

    q IS

    A

    r. r-

    11 11/ OMR

    r

    9r

    k

    _

    C

    4

    o f

    th

    t

    the

    O h

    r a te Bo a r d o f Pha rm acy .

    OHIO ST TE BO RD OF PH RM CY

    77

    South High Street, Room 1702; Columbus, OH 43215-6126

    -Equal Opportunity Employer and Service Provider-

    TEL:

    614/466-4143

    -MAIL: [email protected] AX:

    61 4

    /7

    52-4836

    TTY/7 DD.

    Use the Ohio Relay Service: 1-800/750-0750

    RL: http://www.pharmacy.ohio.gov

    KHN Pharmacy

    c/o Rachael Nicole Schlechty, R.Ph.

    8701 Troy Pike

    Huber Heights, Ohio 45424

    Re:

    hio Terminal Distributor

    License No. 02-1382950

    Dear Ms. Schlechty:

    YOU ARE HEREBY NOTIFIED that, in accordance with the provisions of Chapters 119. and 4729,

    of the Ohio Revised Code, the Ohio State Board of Pharmacy will determine whether or not to

    take action against KHN Pharmacy s license. Prior to any such action, KHN Pharmacy is

    entitled to a hearing before the State Board of Pharmacy on the basis of the following

    allegations:

    1)

    Records of the Board of Pharmacy indicate that KHN Pharmacy is licensed with the

    State Board of Pharmacy as a Terminal Distributor of Dangerous Drugs. Records

    further reflect during the relevant time periods stated herein, Rachael Nicole

    Schlechty, R.Ph. was the Responsible Pharmacist pursuant to Rule 4729-5-11 of the

    Ohio Administrative Code and Sections 4729.27 and 4729.55 of the Ohio Revised

    Code.

    2)

    On or between August 10, 2011 through March 27, 2013, KHN Pharmacy

    Huber/Rachael N. Schlechty, RP, ceased to satisfy the qualifications of a terminal

    distributor of dangerous drugs set forth in Section 4729.55 of the Ohio Revised Code,

    to wit: Rachael Schlechty failed to maintain supervision and control over the custody

    and possession of dangerous drugs at K.H.N. Pharmacy Huber Heights, located at

    8701 Old Troy Pike, Huber Heights, Ohio, which led to the theft of approximately

    88,030 hydrocodone/APAP 7.5/750mg tablets from the pharmacy by a pharmacy

    employee while the pharmacy was open for business. Additionally, KHN Pharmacy

    Huber/Rachael N. Schlechty, RP, failed to have in place any method of detecting the

    losses and failed to monitor for suspicious order, unusual usage, or questionable

    disposition of the drugs. Such conduct is in violation of Rule 4729-9-11 of the Ohio

    Administrative Code. Such conduct, if proven, constitutes violating a rule of the

    board, and ceasing to satisfy the qualifications of a terminal distributor of dangerous

    drugs set forth in Section 4729.55 within the meaning of Section 4729.57 of the Ohio

    Revised Code.

  • 8/10/2019 Khn Pharmacy Rachel Nicole Schlechty

    2/3

    KHN Pharmacy

    c/o Rachael Nicole Schlechty, R.Ph.

    Page 2

    Notice of Opportunity

    For these reasons, the State Board of Pharmacy will determine whether to take action

    pursuant to Section 4729.57 of the Ohio Revised Code.

    YOU ARE HEREBY ADVISED that Section 4729.57 of the Ohio Revised Code provides in

    pertinent part:

    (A) The State Board of Pharmacy may suspend, revoke, or refuse to renew any license

    issued to a terminal distributor of dangerous drugs pursuant to section 4729.54 of

    the Revised Code, or may impose a monetary penalty or forfeiture not to exceed in

    severity any fine designated under the Ohio Revised Code for a similar offense or one

    thousand dollars if the acts committed have not been classified as an offense by the

    Revised Code, for any of the following causes:

    1)

    Making any false material statements in an application for a license

    as a terminal distributor of dangerous drugs;

    2)

    Violating any rule of the board;

    3)

    Violating any provision of this chapter;

    4)

    Violating any provision of the Federal Food, Drug, and Cosmetic

    Act, 52 Stat. 1040 (1938), 21 U.S.C.A. 301, or Chapter 3715. of the

    Revised Code;

    5)

    Violating any provision of the federal drug abuse control laws or

    Chapter 2925. or 3719. of the Revised Code;

    6)

    Falsely or fraudulently promoting to the public a dangerous drug,

    except that nothing in this division prohibits a terminal distributor of

    dangerous drugs from furnishing information concerning a

    dangerous drug to a health care provider or another licensed

    terminal distributor;

    7)

    Ceasing to satisfy the qualifications of a terminal distributor of

    dangerous drugs set forth in Section 4729.55 of the Revised Code.

    8)

    Except as provided in division B) of this section:

    (a) Waiving the payment of all or any part of a deductible or

    copayment that an individual, pursuant to a health insurance

    or health care policy, contract, or plan that covers the

    services provided by a terminal distributor of dangerous

    drugs, would otherwise be required to pay for the services if

    the waiver is used as an enticement to a patient or group of

    patients to receive pharmacy services from that terminal

    distributor;

  • 8/10/2019 Khn Pharmacy Rachel Nicole Schlechty

    3/3

    KHN Pharmacy

    c/o Rachael Nicole Schlechty, R.Ph.

    Page 3

    Notice of Opportunity

    (b) Advertising that the terminal distributor will waive the

    payment of all or any part of a deductible or copayment that

    an individual, pursuant to a health insurance or health care

    policy, contract, or plan that covers the pharmaceutical

    services would otherwise be required to pay for the services.

    YOU ARE FURTHER NOTIFIED that Revoke , as used in Chapters 3719. and 4729. of the

    Revised Code, means to take action against a license rendering such license void and such

    license may not be reissued. Revoke is an action that is permanent against the license and

    licensee. Ohio Administrative Code, 4729-9-01 E)

    YOU ARE FURTHER NOTIFIED, in accordance with the provisions of Chapters 119. and 4729. of

    the Ohio Revised Code, that you are entitled to a hearing before the Ohio State Board of

    Pharmacy, if you request such a hearing within thirty (30) days of the time of the mailing of

    this notice.

    IF YOUR FACILITY DESIRES A HEARING, such request shall be mailed to the State Board of

    Pharmacy, 77 South High Street, Room 1702, Columbus, Ohio 43215-6126. YOUR REQUEST

    MUST BE IN WRITING, AND MUST BE RECEIVED IN THE OFFICE OF THE OHIO STATE BOARD OF

    PHARMACY ON OR PRIOR TO THE THIRTIETH 30TH) DAY FOLLOWING THE MAILING DATE OF

    THIS NOTICE. You may appear at such hearing in person, by or with your attorney, or you may

    present the facility's position, arguments or contentions in writing; and, at this hearing, you

    may also present evidence and examine any witnesses appearing for and against the facility.

    YOU ARE FURTHER ADVISED that if there is no request for such a hearing received by the

    Board on or prior to the thirtieth 30th) day following the mailing of this notice, the Ohio State

    Board of Pharmacy, upon consideration of the aforementioned allegations against your

    facility, may take action without such a hearing.

    BY ORDER OF THE STATE BOARD OF PHARMACY

    Steven W. Schierholt, Esq.

    Executive Director

    SWS/rlc Case No. 2013-1218)

    Registered Mail / Return Receipt

    RE 663 139 078 US

    c: Charissa D. Payer, Assistant Attorney General